These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22952939)

  • 21. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
    Amaral L; Martins M; Viveiros M
    J Antimicrob Chemother; 2007 Jun; 59(6):1237-46. PubMed ID: 17218448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
    Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
    Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
    Hurdle JG; Lee RB; Budha NR; Carson EI; Qi J; Scherman MS; Cho SH; McNeil MR; Lenaerts AJ; Franzblau SG; Meibohm B; Lee RE
    J Antimicrob Chemother; 2008 Nov; 62(5):1037-45. PubMed ID: 18693235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis.
    Islam MI; Han CM; Seo H; Kim S; Mahmud HA; Nam KW; Lee BE; Sadu VS; Lee KI; Song HY
    Int J Antimicrob Agents; 2019 Jul; 54(1):69-74. PubMed ID: 30807817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.
    Idh J; Andersson B; Lerm M; Raffetseder J; Eklund D; Woksepp H; Werngren J; Mansjö M; Sundqvist T; Stendahl O; Schön T
    PLoS One; 2017; 12(7):e0181221. PubMed ID: 28704501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
    Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
    J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
    [No Abstract]   [Full Text] [Related]  

  • 33. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
    Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
    J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    Early JV; Mullen S; Parish T
    PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-antitubercular activity relationship of phenothiazine-type calmodulin antagonists.
    Ratnakar P; Rao SP; Sriramarao P; Murthy PS
    Int Clin Psychopharmacol; 1995 Mar; 10(1):39-43. PubMed ID: 7622803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating
    Aher RB; Sarkar D
    J Biomol Struct Dyn; 2021 Feb; 39(3):889-900. PubMed ID: 31983295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of compound kill kinetics against Mycobacterium tuberculosis.
    Early J; Alling T
    Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.